Hodgkin lymphoma: open trials in Israel

4 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Carmel Medical Center, Haifa · Rambam Med.Center - Hematology Institute, Haifa · Rambam Medical Center, Haifa · Hadassah University Hospita Ein Kerem, Jerusalem · Tel-Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-11-04
NCT07519772
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Carmel Hospital (Site 0602), Haifa · Haddasah Medical Center (Site 0600), Jerusalem · Shaare Zedek Medical Center (Site 0603), Jerusalem · Sheba Medical Center (Site 0601), Ramat Gan · Sourasky Medical Center. (Site 0604), Tel Aviv
Registry updated 2026-10-29
NCT05735704
Early Detection and Screening of Hematological Malignancies - SANGUINE
Research · JaxBio Ltd
Tel Aviv Sourasky Medical Center - TASMC, Tel Aviv
Registry updated 2026-10-15
NCT02332668
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Merck Sharp & Dohme Co. Ltd., Hod HaSharon
Registry updated 2026-07-06

This page is not medical advice. Talk to your doctor before contacting a trial.

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring